Abstract
MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have